Rovati GE - Search Results

1

G protein-coupled receptor (GPCR) pharmacogenomics.

Thompson MD, Reiner-Link D, Berghella A, Rana BK, Rovati GE, Capra V, Gorvin CM, Hauser AS. Thompson MD, et al. Among authors: rovati ge. Crit Rev Clin Lab Sci. 2024 Aug 9:1-44. doi: 10.1080/10408363.2024.2358304. Online ahead of print. Crit Rev Clin Lab Sci. 2024. PMID: 39119983 Review.

2

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.

Kramer JS, Woltersdorf S, Duflot T, Hiesinger K, Lillich FF, Knöll F, Wittmann SK, Klingler FM, Brunst S, Chaikuad A, Morisseau C, Hammock BD, Buccellati C, Sala A, Rovati GE, Leuillier M, Fraineau S, Rondeaux J, Hernandez-Olmos V, Heering J, Merk D, Pogoryelov D, Steinhilber D, Knapp S, Bellien J, Proschak E. Kramer JS, et al. Among authors: rovati ge. J Med Chem. 2019 Sep 26;62(18):8443-8460. doi: 10.1021/acs.jmedchem.9b00445. Epub 2019 Sep 17. J Med Chem. 2019. PMID: 31436984 Free PMC article.

3

Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade.

Sala A, Proschak E, Steinhilber D, Rovati GE. Sala A, et al. Among authors: rovati ge. Biochem Pharmacol. 2018 Dec;158:161-173. doi: 10.1016/j.bcp.2018.10.007. Epub 2018 Oct 11. Biochem Pharmacol. 2018. PMID: 30315753 Review.

4

Binding of leukotriene C4 to human lung membranes.

Nicosia S, Rovati G, Oliva D, Folco G, Mezzetti M, Welton AF. Nicosia S, et al. Prog Biochem Pharmacol. 1985;20:101-7. Prog Biochem Pharmacol. 1985. PMID: 3991609 No abstract available.

5

Identification of specific binding sites for leukotriene C4 in membranes from human lung.

Rovati GE, Oliva D, Sautebin L, Folco GC, Welton AF, Nicosia S. Rovati GE, et al. Biochem Pharmacol. 1985 Aug 15;34(16):2831-7. doi: 10.1016/0006-2952(85)90003-6. Biochem Pharmacol. 1985. PMID: 2992518

6

DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. II. Simultaneous analysis of homologous and heterologous competition curves and analysis blocking and of "multiligand" dose-response surfaces.

Rovati GE, Rodbard D, Munson PJ. Rovati GE, et al. Anal Biochem. 1990 Jan;184(1):172-83. doi: 10.1016/0003-2697(90)90030-d. Anal Biochem. 1990. PMID: 2321753

7

Optimization of experimental design for ligand binding studies: improved estimation of affinity and binding capacity.

Rovati GE, Rodbard D, Munson PJ. Rovati GE, et al. Pharmacol Res. 1989 Nov-Dec;21 Suppl 1:71-2. doi: 10.1016/s1043-6618(89)80057-x. Pharmacol Res. 1989. PMID: 2633192 No abstract available.

8

Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.

Colli S, Maderna P, Tremoli E, Baraldi A, Rovati GE, Gianfranceschi G, Nicosia S. Colli S, et al. Among authors: rovati ge. Biochem Pharmacol. 1985 Jul 15;34(14):2451-7. doi: 10.1016/0006-2952(85)90525-8. Biochem Pharmacol. 1985. PMID: 3893439

9

DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites.

Rovati GE, Rodbard D, Munson PJ. Rovati GE, et al. Anal Biochem. 1988 Nov 1;174(2):636-49. doi: 10.1016/0003-2697(88)90067-x. Anal Biochem. 1988. PMID: 3239764

10

Receptors for cys-leukotrienes in human lung parenchyma: characterization by computer modelling and photoaffinity labelling of binding sites.

Nicosia S, Capra V, Ragnini D, Giovanazzi S, Mezzetti M, Keppler D, Müller M, Rovati GE. Nicosia S, et al. Among authors: rovati ge. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:267-9. Adv Prostaglandin Thromboxane Leukot Res. 1995. PMID: 7732850 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters